跳至主要内容
临床试验/IRCT20210121050096N1
IRCT20210121050096N1已完成1 期

Comparison of safety and efficacy of standard dose and doubling of seasonal flu vaccine in patients receiving kidney transplantation in Imam Khomeini Hospital, 2021

Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • At least 18 years old
  • At least three months have passed since their transplant.

排除标准

  • Treatment for acute transplantation reject
  • Acute febrile illness in the last two weeks
  • Previous life-threatening reactions to vaccine products (such as Guillain-Barré syndrome)
  • Patients with any autoimmune disease receiving corticosteroids or immunosuppressive drugs.
  • Patients who have recently underwent kidney transplant.

研究者

相似试验